WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, November 14, 2007, 27(46):12700-12706; doi:10.1523/JNEUROSCI.3371-07.2007

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (19)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Volkow, N. D.
Right arrow Articles by Wong, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Volkow, N. D.
Right arrow Articles by Wong, C.

 Previous Article  |  Next Article 

Behavioral/Systems/Cognitive
Profound Decreases in Dopamine Release in Striatum in Detoxified Alcoholics: Possible Orbitofrontal Involvement

Nora D. Volkow,1,2 Gene-Jack Wang,3 Frank Telang,2 Joanna S. Fowler,3 Jean Logan,3 Millard Jayne,2 Yeming Ma,2 Kith Pradhan,4 and Christopher Wong3

1National Institute on Drug Abuse, Bethesda, Maryland 20892, 2Laboratory of Neuroimaging, National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland 20892, 3Medical Department, Brookhaven National Laboratory, Upton, New York 11973, and 4Department of Applied Mathematics, State University of New York at Stony Brook, Stony Brook, New York 11794

Correspondence should be addressed to Dr. Nora D. Volkow, National Institute on Drug Abuse, 6001 Executive Boulevard, Room 5274, Bethesda, MD 20892. Email: nvolkow{at}nida.nih.gov

The value of rewards (natural rewards and drugs) is associated with dopamine increases in the nucleus accumbens and varies as a function of context. The prefrontal cortex has been implicated in the context dependency of rewards and in the fixated high value that drugs have in addiction, although the mechanisms are not properly understood. Here we test the hypothesis that the prefrontal cortex regulates the value of rewards by modulating dopamine increases in nucleus accumbens and that this regulation is disrupted in addicted subjects. We used positron emission tomography to evaluate the activity of the prefrontal cortex (measuring brain glucose metabolism with [18F]fluorodeoxyglucose) and dopamine increases (measured with [11C]raclopride, a D2/D3 receptor ligand with binding that is sensitive to endogenous dopamine) induced by the stimulant drug methylphenidate in 20 controls and 20 detoxified alcoholics, most of whom smoked. In all subjects, methylphenidate significantly increased dopamine in striatum. In ventral striatum (where the nucleus accumbens is located) and in putamen, dopamine increases were associated with the rewarding effects of methylphenidate (drug liking and high) and were profoundly attenuated in alcoholics (70 and 50% lower than controls, respectively). In controls, but not in alcoholics, metabolism in orbitofrontal cortex (region involved with salience attribution) was negatively associated with methylphenidate-induced dopamine increases in ventral striatum. These results are consistent with the hypothesis that the orbitofrontal cortex modulates the value of rewards by regulating the magnitude of dopamine increases in the ventral striatum and that disruption of this regulation may underlie the decreased sensitivity to rewards in addicted subjects.

Key words: PET; dopamine; alcohol; orbitofrontal cortex; ventral striatum; reward


Received July 25, 2007; revised Oct. 2, 2007; accepted Oct. 2, 2007.

Correspondence should be addressed to Dr. Nora D. Volkow, National Institute on Drug Abuse, 6001 Executive Boulevard, Room 5274, Bethesda, MD 20892. Email: nvolkow{at}nida.nih.gov




This article has been cited by other articles:


Home page
Schizophr BullHome page
N. D. Volkow
Substance Use Disorders in Schizophrenia--Clinical Implications of Comorbidity
Schizophr Bull, May 1, 2009; 35(3): 469 - 472.
[Abstract] [Full Text] [PDF]


Home page
Phil Trans R Soc BHome page
N. D Volkow, G.-J. Wang, J. S Fowler, and F. Telang
Overlapping neuronal circuits in addiction and obesity: evidence of systems pathology
Phil Trans R Soc B, October 12, 2008; 363(1507): 3191 - 3200.
[Abstract] [Full Text] [PDF]



-
-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-